Thomas A. Davis - Executive VP & CMO, Celldex Therapeutics, Inc

As of June 16, 2017


Thomas A. Davis Net Worth

  • Net worth is estimated to be at least $193.44K
  • Owns at least 1,011 units of Celldex Therapeutics, Inc stock

Thomas A. Davis Trading

  • Largest purchase of shares was 2,500 units , worth over $9.44K on September 17, 2010
  • In total has made about 10 transactions over 8 years
  • Usually trades in June, with the busiest year in 2010
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Thomas A. Davis Mailing Address

  • Mailing address is 65 West Watkins Mill Road Gaithersburg MD 20878 MD

Celldex Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm

Celldex Therapeutics, Inc Insider Trading

  • The most recent transaction was 9,500 units sold on December 28, 2021 by Samuel Bates Martin worth over $399K
  • In the last 13 years, insiders at Celldex Therapeutics, Inc sold an estimated value of $23.93M and bought an estimated value of $4.55M
  • The most active traders are Gerald McMahon, Director,  Avery W Catlin, Sr. VP & CFO,  and Anthony S Marucci, President & CEO
  • Insider trading is most common in June, with the busiest year in 2018

Celldex Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1